Correlation Between CAMP4 THERAPEUTICS and CEL SCI
Can any of the company-specific risk be diversified away by investing in both CAMP4 THERAPEUTICS and CEL SCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CAMP4 THERAPEUTICS and CEL SCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CAMP4 THERAPEUTICS PORATION and CEL SCI Corp, you can compare the effects of market volatilities on CAMP4 THERAPEUTICS and CEL SCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CAMP4 THERAPEUTICS with a short position of CEL SCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of CAMP4 THERAPEUTICS and CEL SCI.
Diversification Opportunities for CAMP4 THERAPEUTICS and CEL SCI
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between CAMP4 and CEL is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding CAMP4 THERAPEUTICS PORATION and CEL SCI Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CEL SCI Corp and CAMP4 THERAPEUTICS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CAMP4 THERAPEUTICS PORATION are associated (or correlated) with CEL SCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CEL SCI Corp has no effect on the direction of CAMP4 THERAPEUTICS i.e., CAMP4 THERAPEUTICS and CEL SCI go up and down completely randomly.
Pair Corralation between CAMP4 THERAPEUTICS and CEL SCI
Given the investment horizon of 90 days CAMP4 THERAPEUTICS PORATION is expected to generate 1.25 times more return on investment than CEL SCI. However, CAMP4 THERAPEUTICS is 1.25 times more volatile than CEL SCI Corp. It trades about 0.2 of its potential returns per unit of risk. CEL SCI Corp is currently generating about -0.04 per unit of risk. If you would invest 164.00 in CAMP4 THERAPEUTICS PORATION on August 2, 2025 and sell it today you would earn a total of 239.00 from holding CAMP4 THERAPEUTICS PORATION or generate 145.73% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
CAMP4 THERAPEUTICS PORATION vs. CEL SCI Corp
Performance |
| Timeline |
| CAMP4 THERAPEUTICS |
| CEL SCI Corp |
CAMP4 THERAPEUTICS and CEL SCI Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CAMP4 THERAPEUTICS and CEL SCI
The main advantage of trading using opposite CAMP4 THERAPEUTICS and CEL SCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CAMP4 THERAPEUTICS position performs unexpectedly, CEL SCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CEL SCI will offset losses from the drop in CEL SCI's long position.| CAMP4 THERAPEUTICS vs. CEL SCI Corp | CAMP4 THERAPEUTICS vs. Precision BioSciences | CAMP4 THERAPEUTICS vs. Sutro Biopharma | CAMP4 THERAPEUTICS vs. Artiva Biotherapeutics, Common |
| CEL SCI vs. CAMP4 THERAPEUTICS PORATION | CEL SCI vs. Precision BioSciences | CEL SCI vs. Sutro Biopharma | CEL SCI vs. Relmada Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |